The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
|Articles|December 13, 2022
Supplements and Featured Publications
- Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
- Volume 28
- Issue 16
Participating Faculty: Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
Author(s)Kavita V. Nair, PhD
Advertisement
Faculty
Kavita V. Nair, PhD
Professor of Neurology and Pharmacy
Department of Neurology
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Faculty Disclosures
This faculty member has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Kavita V. Nair, PhD
CONSULTANCIES OR PAID ADVISORY BOARDS
Genentech, Novartis, PhRMA Foundation, TG Therapeutics, Inc
GRANTS PENDING
Bristol Myers Squibb
GRANTS RECEIVED
Bristol Myers Squibb, Genentech, Novartis
HONORARIA
PTCD Education
MEETING/CONFERENCE ATTENDANCE
American Academy of Neurology
Articles in this issue
almost 4 years ago
Role of the Bruton Tyrosine Kinase Pathway in Multiple SclerosisAdvertisement
Related to this article
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Cleveland roundtable panelists across 4 disease states name access, not evidence, as the shared barrier to care.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Inconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
3
Medicaid Obesity GLP-1 Coverage May Offset Some Diabetes-Labeled Use
4
FAQ: How Payers Can Close HIV Prevention and PrEP Access Gaps
5